Franklin Genomic Advancements ETF
Franklin Genomic Advancements ETF (HELX) Covered Calls
As of September 23, 2026, HELX has 8 covered call opportunities in the coming three months. Return ranges from 0.2 to 7.1% until expiration. Annualized return ranges from 0.2 to 11.8%. The nearest expiration is November 20, 2026. Maximum potential profit is $307.
Read more
Running HELX covered calls helps you generate consistent income from Franklin Genomic Advancements ETF's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Franklin Genomic Advancements ETF involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best HELX covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if HELX stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling HELX covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Franklin Genomic Advancements ETF covered call is worth writing.
The fund seeks capital appreciation by investing in equity securities inside and outside of the United States, including developing or emerging markets. The fund invests in companies that are relevant to its investment theme of genomic advancements that the investment manager believes are substantially focused on/or are expected to substantially benefit from extending and enhancing the quality of human and other life (e.g., animals) by incorporating technological and scientific developments, improvements and advancements in the field of genomics into their business.
Income-focused investors, long-term HELX holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling HELX covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Franklin Genomic Advancements ETF covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryExchange Traded Fund
- SectorFinancial
- IV percentile13.49% Subdued
- Market cap (M$)—
- 52 weeks high-1.94%
- 52 weeks low44.23%
- Analyst recommendation—
- Target price—
- Dividend—
- Payout ratio—
- Earnings date—
- P/E—
- Future P/E—
- EPS (ttm)—
- EPS growth next 5 years—
As of September 23, 2026
| 2027-02-19 | 149 | 45.00 | 4.70 | 0.05 | 6.80 | 207.00 | 4.82 | 11.80 | -0.12 | +0.50 | 2 | 6.75 |
| 2027-05-21 | 240 | 46.00 | 7.03 | 0.05 | 6.80 | 307.00 | 7.14 | 10.86 | -0.12 | +0.48 | 0 | 6.75 |
| 2027-05-21 | 240 | 45.00 | 4.70 | 0.05 | 7.20 | 207.00 | 4.82 | 7.32 | -0.12 | +0.51 | 0 | 7.15 |
| 2027-02-19 | 149 | 44.00 | 2.37 | 0.15 | 7.10 | 117.00 | 2.72 | 6.67 | -0.35 | +0.53 | 0 | 6.95 |
| 2027-05-21 | 240 | 44.00 | 2.37 | 0.05 | 7.80 | 107.00 | 2.49 | 3.79 | -0.12 | +0.55 | 0 | 7.75 |
| 2026-11-20 | 58 | 43.00 | 0.05 | 0.05 | 3.70 | 7.00 | 0.16 | 1.02 | -0.12 | +0.54 | 0 | 3.65 |
| 2027-02-19 | 149 | 43.00 | 0.05 | 0.05 | 7.70 | 7.00 | 0.16 | 0.40 | -0.12 | +0.57 | 0 | 7.65 |
| 2027-05-21 | 240 | 43.00 | 0.05 | 0.05 | 8.30 | 7.00 | 0.16 | 0.25 | -0.12 | +0.59 | 0 | 8.25 |
As of September 23, 2026
Sell covered calls with the data behind you
Find the best HELX covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→